Amphastar Pharmaceuticals
AMPH
#4026
Rank
NZ$3.91 B
Marketcap
$80.90
Share price
4.82%
Change (1 day)
-9.10%
Change (1 year)

Amphastar Pharmaceuticals (AMPH) - Total debt

Total debt on the balance sheet as of June 2024 : NZ$1.03 Billion

According to Amphastar Pharmaceuticals's latest financial reports the company's total debt is NZ$1.03 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Amphastar Pharmaceuticals - Total debt on balance sheet (from 2013 to 2024)

Total debt by year

Year Total debt Change
2023-12-31NZ$0.98 B510.35%
2022-12-31NZ$0.16 B5.44%
2021-12-31NZ$0.15 B64.36%
2020-12-31NZ$93.23 M-5.76%
2019-12-31NZ$98.92 M32.15%
2018-12-31NZ$74.85 M12.74%
2017-12-31NZ$66.39 M21.93%
2016-12-31NZ$54.45 M-9.31%
2015-12-31NZ$60.04 M7.67%
2014-12-31NZ$55.77 M42.46%
2013-12-31NZ$39.15 M-15.25%
2012-12-31NZ$46.19 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
NZ$96.47 M-90.72%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$26.02 M-97.50%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.48 M-99.95%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$15.5 M-98.51%๐Ÿ‡บ๐Ÿ‡ธ USA